фолликулярная лимфомасимптом интоксикации1.Khalifa K., Alkilani A., Hisman I. et al. Evaluation of Biochemical Markers as Prognostic Factors in Malignant Lymphoma. J of Egyptian Nat Cancer Inst 2008;20(1):47-54. PMID: 19847281.2.Attia F., Hassan A., Maraghy E. et al. The clinical significance of suppressor of cytokine signaling-3 mRNA expression in patients with non-Hodgkin’s lymphoma with chemotherapy. Cancer Biomark 2011 -2012;11(1):41-7. DOI: 10.3233/ CBM-2012-0262. PMID: 22820139.3.Ame-Thomas P., Maby-EI Hajjami H., Monvoisin C. et al. Human mesenchymal stem cells isolated from bone marrow and lymphoid organs support tumor B-cell growth: role of stromal cells in follicular lymphoma pathogenesis. Blood 2007;109(2):693-702. DOI: 10.1182/ blood-2006-05-020800. PMID: 16985173.4.Wagner-Jonston N.D., Link B.K., Byrtek M. et al. Outcomes of transformer follicular lymphoma in the modern era: a report from the National LymphoCare Study (NLCS). Blood 2015; 126(7):851-57. DOI: 10.1182/blood-2015-01-621375. PMID: 26105149. PMCID: PMC4543911.5.Ardeshna K.M., Smith P., Norton A. et al. Long-term effect of a watch and wait policy versus immediate systemic treatment for asymptomatic advanced-stage non-Hodgkin lymphoma: a randomized controlled trial. Lancet 2003;362(9386):516-22. PMID: 12932382.6.Kurzrock R., Reman J., Cabanillas F. et al. Serum Interleukin 6 levels Are Elevated in Lymphoma Patients and Correlate with Survival in advanced Hodgkin’s Disease and B symptoms. Cancer Res 1993;53(9):2118-22. PMID: 8481913.7.Quesada J., Talpaz M., Rios A. et al. Clinical toxicity of interferons in cancer patients: a review. J Clin Oncol 1986;4:234-43. PMID: 2418169.8.Feinberg B., Kurzrock R., Talpaz M. et al. A Phase 1 trial of intravenously-administered recombinant tumor necrosis factor-alpha in cancer patients. J Clin Oncol 1988;6:1328-34. PMID: 3411344.9.Tewari A., Buhles W., Starnes H. Preliminary report: effect of interleukin-1 on platelet couts. Lancet 1990;336:712-4. PMID: 1975894.10.Opp M., Obal F., Cady A. et al. Interleukin-6 is pyrogenic but not somnogenic. Physiol.& Behav 1989;45:1069-72. PMID: 2476835.11.Means R.T. Jr. Pathogenesis of the anemia of chronic disease: a cytokine-mediated anemia. Stem Cells 1995;13:32-7. DOI: 10.1002/stem. 5530130105. PMID: 7719246.12.Salvarini C., Casali B., Salvo D. et al. The role of interleukine-1, erythropoietin and red cell bound immunoglobulins in the anemia of rheumatoid arthritis. Clin Exp Rheumatol 1991;9:241-6. PMID: 1879083.13.Swerdlow S.H., Campo E., Harris N.L. et al. (Eds.) WHO classification of tumours of haematopoietic and lymphoid tissues. WHO Press, 2008.14.Cheson B.D., Horning S.J., Coiffier B. et al. Report of an international workshop to standardize response criteria for non-Hodgkin’s lymphomas. NCI Sponsored International Working Group. J Clin Oncol 1999;17:1244. PMID: 10561185.